39 related articles for article (PubMed ID: 31353915)
1. Successful multidisciplinary treatment of the rare pathology of vulvar Crohn's disease.
Al Yacoub R; Brown K; Ladna M
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37844980
[TBL] [Abstract][Full Text] [Related]
2. Acute jejunoileal obstruction due to a pseudopolyp in a child with undiagnosed crohn disease: a case report.
Christianakis E; Pashalidis N; Kokkinou S; Pitiakoudis M; Mplevrakis E; Chorti M; Rizos S; Filippou D
J Med Case Rep; 2008 Feb; 2():54. PubMed ID: 18289386
[TBL] [Abstract][Full Text] [Related]
3. Regression of giant pseudopolyps in inflammatory bowel disease.
Choi YS; Suh JP; Lee IT; Kim JK; Lee SH; Cho KR; Park HJ; Kim DS; Lee DH
J Crohns Colitis; 2012 Mar; 6(2):240-3. PubMed ID: 22325179
[TBL] [Abstract][Full Text] [Related]
4. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
5. Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.
Rivière P; D'Haens G; Peyrin-Biroulet L; Baert F; Lambrecht G; Pariente B; Bossuyt P; Buisson A; Oldenburg B; Vermeire S; Laharie D
Am J Gastroenterol; 2021 Jan; 116(1):134-141. PubMed ID: 33177349
[TBL] [Abstract][Full Text] [Related]
6. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.
Colombel JF; Reinisch W; Mantzaris GJ; Kornbluth A; Rutgeerts P; Tang KL; Oortwijn A; Bevelander GS; Cornillie FJ; Sandborn WJ
Aliment Pharmacol Ther; 2015 Apr; 41(8):734-46. PubMed ID: 25728587
[TBL] [Abstract][Full Text] [Related]
7. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
8. Regression of a giant pseudopolyp in a patient with colonic Crohn's disease after therapy with infliximab.
Sánchez Melgarejo JF; Navarro B; Rubio JM; Bastida G; Nos P
Rev Esp Enferm Dig; 2019 Oct; 111(10):801-803. PubMed ID: 31353915
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Chande N; Townsend CM; Parker CE; MacDonald JK
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
11. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Chande N; Tsoulis DJ; MacDonald JK
Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
[TBL] [Abstract][Full Text] [Related]
12. Biological therapy in the management of recent-onset Crohn's disease: why, when and how?
Löwenberg M; Peppelenbosch M; Hommes D
Drugs; 2006; 66(11):1431-9. PubMed ID: 16906776
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
